Robin T Nelson
Overview
Explore the profile of Robin T Nelson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferruz N, Doerr S, Vanase-Frawley M, Zou Y, Chen X, Marr E, et al.
Sci Rep
. 2019 Apr;
9(1):6076.
PMID: 30967561
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
2.
Ferruz N, Doerr S, Vanase-Frawley M, Zou Y, Chen X, Marr E, et al.
Sci Rep
. 2018 Jan;
8(1):897.
PMID: 29343833
The recent increase in the number of X-ray crystal structures of G-protein coupled receptors (GPCRs) has been enabling for structure-based drug design (SBDD) efforts. These structures have revealed that GPCRs...
3.
Johnson D, Drummond E, Grimwood S, Sawant-Basak A, Miller E, Tseng E, et al.
J Pharmacol Exp Ther
. 2012 Mar;
341(3):681-91.
PMID: 22408061
5-Hydroxytryptamine (5-HT)(4) receptor agonists reportedly stimulate brain acetylcholine (ACh) release, a property that might provide a new pharmacological approach for treating cognitive deficits associated with Alzheimer's disease. The purpose of...
4.
Paradis T, Cole S, Nelson R, Gladue R
J Invest Dermatol
. 2007 Sep;
128(3):628-33.
PMID: 17882271
CCR6 is expressed in a number of dermatological inflammatory diseases. Here, we report that mice sensitized with the hapten oxazolone had increased numbers of CCR6+ T cells in the draining...
5.
Gladue R, Cole S, Roach M, Tylaska L, Nelson R, Shepard R, et al.
J Immunol
. 2006 Feb;
176(5):3141-8.
PMID: 16493073
We previously described the in vitro characteristics of the potent and selective CCR1 antagonist, CP-481,715. In addition to being selective for CCR1 vs other chemokine receptors, CP-481,715 is also specific...